Velocity is Now X-37

The team of experienced pharmaceutical developers from Velocity Pharmaceutical Development have joined forces with Atomwise to cofound X-37. At X-37, we use AI to discover better drug candidates faster then our team of industry veterans rapidly takes those candidates into clinical trials.

About VPD

Velocity Pharmaceutical Development (VPD) was established in 2011 by Presidio Partners as an alternative model to develop attractive drug candidates that would otherwise be funded as part of a broader company financing or not be funded due to strategic reasons or resource limitations.

During our time at VPD, we created and managed four companies that advanced single-asset drug development, which advanced to important milestones including acquisition, IPO, partnering, and an IND-ready asset.